Foley & Lardner hosted an Executive Briefing Series program examining concierge medicine. This interactive session, moderated by Foley Partner Michael L. Blau, explored the pros and cons, ethical dimensions, and legal implications of retainer-based medical practices.
Speakers included:
- Jordan Busch, M.D., of Personal Physicians Healthcare, the first concierge practice in Massachusetts
- Michael L. Blau, Foley Partner and Chair of the Health Ventures Practice, who has architected pioneering concierge practice business models
- Gerry Zitoli, Assistant General Counsel, Tufts Health Plan, who will provide the payors’ perspective on concierge medicine
- Jeff Butler, founder of Privia Health, a novel concierge medicine network company, who will discuss national developments in concierge medicine arrangements
Questions addressed included:
- What providers are converting to concierge medicine, and why?
- Which patients are choosing concierge practices?
- What are the business models for concierge practices, and how do they differ?
- What are the implications of concierge medicine for our health care delivery system?
- What are the legal and business considerations in establishing a concierge practice?
- What is the future of concierge medicine in an age of health care reform?
Concierge Medicine: An Evolution in the Delivery of Primary Care is part of the Foley Executive Briefing Series.
People
Related Insights
May 22, 2026
Foley Viewpoints
New Lawsuit Tests the Limits of Donor-Advised Fund Advisory Privileges
A recent lawsuit seeking to clarify the extent of an advisor’s privileges with respect to a donor-advised fund (DAF) has been filed in…
May 22, 2026
Energy Current
FERC Just Rewrote the Rules for Natural Gas Infrastructure. Here’s What It Means.
Yesterday’s unanimous FERC vote is the most significant natural gas permitting reform in two decades — and its practical implications…
May 22, 2026
Foley Viewpoints
What the Federal Circuit’s Poultry Patent Ruling Says About 'About'
The decision does not appear to prohibit the use of terms such as "about" or "approximately." Rather, it reinforces that such terms may be acceptable where the patent record provides sufficient context for understanding the scope of the claimed range.